Journals / Türk Hijyen ve Deneysel Biyoloji Dergisi / 2016 / Cilt: 73 - Sayı: 1

The nature of enterococcal biofilm structure, a risk factor for human and animal health

İnsan ve hayvan sağlığı açısından risk oluşturan enterokokal biyofilm yapısının doğası

Pages
71–80
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In all over the world, to achieve better results at eradication of thisorganism; structure and molecular mechanism of biofilm need to be understood for determination of new drug dosages and new treatment strategies to eradicate biofilm.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Enterococci, generally considered as normal bowel commensals, are also recognized as opportunistic pathogens and one of the top three bacterias which are the causes of bowine mastitis, nosocomial bloodstream, surgical site, and urinary tract infections as well.
📊
Key Findings & Data:Enterococcus faecalis is the most common enterococci species, and it is responsible for 80-90% of human and animal enterococcal infections.
💡
Conclusion & Impact:In all over the world, to achieve better results at eradication of thisorganism; structure and molecular mechanism of biofilm need to be understood for determination of new drug dosages and new treatment strategies to eradicate biofilm.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Enterococci, generally considered as normal bowel commensals, are also recognized as opportunistic pathogens and one of the top three bacterias which are the causes of bowine mastitis, nosocomial bloodstream, surgical site, and urinary tract infections as well. Enterococcus faecalis is the most common enterococci species, and it is responsible for 80-90% of human and animal enterococcal infections. Enterococcus faecium accounts for the remainder of infections caused by Enterococcus spp. Biofilms are highly organized structures formed by one or more microorganism species bound together by a carbonhydrate matrix that contain water channels to deliver nutrients and removes wastes. Biofilm structure works as a shield with its exopolysaccharide and protein film layer and often harder to kill them than their planktonic counterparts. Biofilm bacteria are up to 1000 times more resistant to phagocytosis, antibodies and antibiotics. Enterococci can infect humans and domestic animals because of their many virulence factors associated with biofilm formation including gelatinase, aggregation substance, capsule formation, enterococcal surface protein. Furthermore, since they are also resistant against antibiotics such as vancomycin that used at treatment, it is really difficult to eradicate. Many strains of enterococci are resistant to one or more antibiotics and biofilms are thought to contribute to this resistance. In all over the world, to achieve better results at eradication of thisorganism; structure and molecular mechanism of biofilm need to be understood for determination of new drug dosages and new treatment strategies to eradicate biofilm.

Özet

Enterokoklar, genellikle komensali olarak değerlendirilseler de aynı zamanda fırsatçı patojendirler ve sığır mastitisinin yanı sıra nozokomiyal kan dolaşımı, ameliyat bölgesi ve üriner sistem enfeksiyonu etkenleri arasında yer alan ilk üç bakteriden biridir. Enterokok türleri içerisinde Enterococcus faecalis insan ve hayvanlardaki enterokokal enfeksiyonların %80-90'ından sorumludur. Geriye kalan Enterococcus spp. enfeksiyonlardan sorumlu olan tür ise Enterococcus faecium'dur. Biyofilm yapısı; bir ya da daha fazla mikroorganizma türünün karbonhidrat bir matriks ile bir arada tutulduğu, besinlerin taşınması ve atıkların uzaklaştırılması amacı ile su kanalları ihtiva eden yüksek organizasyonlu yapılardır. Biyofilm yapısı, ekzopolisakkarit ve protein film tabakası ile içerisinde bulunan mikroorganizmalar için bir kalkan görevi görür ve bu yapıdaki bakterileri öldürmek, planktonik formdaki bakterilere kıyasla çok daha zordur. Biyofilm yapısındaki bakterilerin fagositoz, antikor ve antibiyotiklere karşı 1000 kata kadar daha dirençli oldukları bilinmektedir. Enterokoklar; jelatinaz, agregasyon maddeleri, kapsül yapısı ve enterokokal yüzey proteini gibi biyofilm yapısına katılan çeşitli virülans faktörler sayesinde insanları ve evcil hayvanları enfekte ederler. Ayrıca, tedavide kullanılan vankomisin gibi antimikrobiyal maddelere karşı daha dirençli olduklarından eradikasyonları oldukça zordur. Enterokok türlerinin çoğu en az bir antibiyotiğe karşı dirençlidir ve biyofilm yapısının bu dirence katkıda bulunduğu düşünülmüktedir. Tüm dünyada oldukça önemli düzeyde enfeksiyona neden olan bu organizmanın eradikasyonunda daha etkin başarının eldesi için, biyofilm yapısının aşamalarının ve moleküler mekanizmalarının anlaşılması ve bu yapı esas alınarak yeni ilaç dozlarının ve tedavi yollarının belirlenmesi gerekmektedir.

🔖

Cite This Article

AKÇELİK, N., DIANI, M., ARIAFAR, M. N. (2022). The nature of enterococcal biofilm structure, a risk factor for human and animal health. Türk Hijyen ve Deneysel Biyoloji Dergisi, Cilt: 73 - Sayı: 1, 71–80. https://ajindex.com/articles/625030

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Murcia JA, Collins MD. Enterococcus sulfureus, a new yellow-pigment ed Enterococcus species. FEMS Microbiol Lett, 1991; 64: 69-74
  2. Murray BE, Weinstock GM. Enterococci: new aspects of an old organism. Proc Assoc Am Physicians, 1999; 111: 328-334
  3. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medicalsurgical intensive care units in the United States. Infect Control Hosp Epidemiol, 2002; 1: 510-5
  4. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis, 2002; 8: 881-90
  5. Olson ME, Ceri H, Douglas W. Biyofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res, 2002; 66: 86-92
  6. Ira P, Sujatha S, Chandra PS. Virulence factors in clinical and commensal isolates of Enterococcus species. Indian J Pathol Microbiol, 2013; 56: 24-30
  7. Jones M E, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study 2000-2002. Ann Clin Microbiol Antimicrob, 2004; 3: 14
  8. Moellering RC. Jr: Enterococcus species, Streptococcus bovis and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed, Philadelphia: Churchill Livingstone, 1999: 2411- 241
  9. Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res, 2008; 128: 111-21
  10. Seno Y, Kariyama R, Mitsuhata R, Monden K, Kumon H. Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract. Acta Med Okayama, 2005; 59: 79-87
  11. Edmond MB, Ober JF, Dawson JD. Vancomycinresistant enterococcal bacteremia: Natural history and attributable mortality. Clin Infect, 1996; 23: 1234
  12. Sutherland IW. Biofilm exopolysaccharites: A strong and sticky framework. Microbiol, 2001; 147: 3-9
  13. Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg, 2004; 12: 185-90
  14. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infection. Science, 1999; 284: 1318-22
  15. Davey ME, O'toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev, 2000; 64: 847-67
  16. Bothwell MR, Smith AL, Phillips T. Recalcitrant otorrhea due to Pseudomonas biofilm. Otolaryngol Head Neck Surg, 2003; 129: 599-60
  17. Donlan RM, Costerton JW. Biofilms: survival mechanisms